Four details:
1. The company said it plans to use net proceeds from the public offering for general corporate purposes.
2. J.P. Morgan Securities and Jefferies are acting as lead book-running managers. The acting joint book-running managers for the public offering are Barclays Capital, KKR Capital Markets and Macquarie Capital.
3. Surgery Partners reported 2020 revenue of $1.86 billion on Jan. 11 and reaffirmed its EBITDA guidance as being $250 million to $260 million. The company had 116 ASCs and 17 short-stay surgical hospitals in its portfolio at the end of the year.
4. Despite the pandemic, Surgery Partners made 10 acquisitions last year for around $160 million and plans to deploy more than $100 million in capital in 2021.
More articles on surgery centers:
How will the ASC industry change in the next 3 years? 5 insights
Urologist’s estate pays $1.75M to settle ASC kickback allegations: 4 details
The top ASC supply chain issues? Allocation, allocation, allocation
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
